Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 71
(1)
◽
pp. 35-43
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 22
(7)
◽
pp. 617-624
◽
Keyword(s):